Add BrightSurf on Google Email

Chinese Neurosurgical Journal article finds that flow diversion devices are exceptionally safe

A long-term study of patients treated with flow diversion devices (FDDs) for intracranial aneurysms revealed excellent safety profiles, with no significant differences in outcomes between various FDD platforms. The study found that multiple FDDs were associated with a higher risk of insufficient closure and delayed complications.

SourceChinese Neurosurgical Journal·JournalChinese Neurosurgical Journal·TypeData/statistical analysis·DateMay 18, 2026

Chinese Medical Journal study examines rising neurological disease burden in China

A recent Chinese Medical Journal study analyzed data from 1990 to 2021, revealing a significant increase in neurological disorders such as dementia, Parkinson's disease, and ischemic stroke. The study identified a turning point coinciding with the COVID-19 pandemic, highlighting the need for coordinated national strategies to address t...

SourceChinese Medical Journals Publishing House Co., Ltd.·JournalChinese Medical Journal·TypeMeta-analysis·DateMay 14, 2026

Chinese Neurosurgical Journal reports KRAS gene as key driver for brain arteriovenous malformation

A study published in Chinese Neurosurgical Journal reports KRAS gene overexpression associated with brain arteriovenous malformation (bAVM) pathogenesis. The research found altered gene expression profiles linked to cell adhesion, signaling, and mitochondrial function, suggesting KRAS-driven molecular alterations play a role in bAVM de...

SourceChinese Neurosurgical Journal·JournalChinese Neurosurgical Journal·TypeExperimental study·DateMay 13, 2026

New experimental drug may restore movement after stroke

Researchers discovered that strokes cause a chain reaction within the brain, leading to neuronal cell death. They found that blocking collagen production can prevent this damage and even restore motor function in paralyzed monkeys. The new drug KDS12025 reduces hydrogen peroxide levels and prevents the entire process from being triggered.

SourceInstitute for Basic Science·JournalCell Metabolism·TypeExperimental study·DateApr 27, 2026

Low-dose triple-pill cut risk of recurrent stroke by about 40%, global trial shows

A global trial involving 1,670 patients with intracerebral haemorrhage found that treatment with a single pill combination of three low-dose blood pressure medicines reduced the risk of another stroke by 39%. The study showed significant benefits in reducing major cardiovascular events and improving blood pressure control.

SourceGeorge Institute for Global Health·JournalNew England Journal of Medicine·TypeRandomized controlled/clinical trial·DateApr 22, 2026

Patients with higher markers of marginalization more likely to rely on emergency departments for concussion care, study finds

A new study found that patients experiencing socioeconomic marginalization are more likely to seek initial concussion care in hospital emergency departments, leading to lower follow-up rates. Patients without family physicians were up to 70% less likely to follow up.

SourceInstitute for Clinical Evaluative Sciences·JournalJAMA Network Open·TypeObservational study·DateApr 22, 2026

Application of a new combined surgical strategy in spontaneous supratentorial intracerebral hemorrhage

A new combined surgical strategy outperforms conventional methods in treating spontaneous supratentorial intracerebral hemorrhage by enabling rapid ICP reduction and efficient hematoma clearance. This approach showed improved outcomes in selected patients, but further studies are needed to validate its efficacy.

SourceXia & He Publishing Inc.·JournalNeurosurgical Subspecialties·DateApr 19, 2026

New drug combination doubles down on Alzheimer's treatments

Researchers at the University of Waterloo have discovered a safer and more effective way to treat Alzheimer's disease by combining anti-amyloid antibodies with molecules found in grapes, berries, peanuts, and turmeric. This combination approach neutralizes amyloid protein clumping in the brain, leading to better outcomes.

SourceUniversity of Waterloo·JournalACS Chemical Neuroscience·TypeExperimental study·DateApr 9, 2026

Chinese Medical Journal article white matter lesions modifying endovascular therapy outcomes in large ischemic core stroke: A secondary analysis of the ANGEL-ASPECT trial

A secondary analysis of the ANGEL-ASPECT trial found EVT to be beneficial for patients with anterior-circulation LVO and a large ischemic core and absent-to-moderate white matter lesions. In contrast, those with severe WMLs showed less pronounced benefits, suggesting uncertainty about EVT's efficacy in this subgroup.

SourceChinese Medical Journals Publishing House Co., Ltd.·JournalChinese Medical Journal·TypeData/statistical analysis·DateApr 7, 2026

Large clinical RCT trial finds no clear added benefit of catheter ablation for preventing recurrent stroke in patients with atrial fibrillation

A nationwide Japanese trial found that catheter ablation did not reduce the risk of recurrent stroke or major cardiovascular events in patients with atrial fibrillation who had recently experienced a stroke. The study, which enrolled 251 patients and followed them for over three years, suggests that routine addition of catheter ablatio...

SourceKumamoto University·JournalJAMA Neurology·TypeRandomized controlled/clinical trial·DateMar 31, 2026

New brain–heart guideline takes holistic approach to chronic disease management

The new brain–heart clinical practice guideline provides a holistic approach to managing chronic diseases by integrating neurologic and mental health evidence with cardiovascular guidance. The guideline aims to improve the management of patients with concurrent brain and heart diseases, which often co-occur and share similar risk factors.

SourceCanadian Medical Association Journal·JournalCanadian Medical Association Journal·TypeLiterature review·DateMar 30, 2026

Gut microbiota and the gut–brain axis: Mechanisms and therapeutic hopes for brain diseases

The gut microbiota influences the central nervous system (CNS) through neural, immune, endocrine, and metabolic pathways. Dysregulation of this axis is linked to various neuropsychiatric and neurodegenerative disorders, including depression, schizophrenia, Alzheimer's disease, and Parkinson's disease.

SourceChinese Medical Journals Publishing House Co., Ltd.·JournalChinese Medical Journal·TypeLiterature review·DateMar 19, 2026

AAN issues guidance on the use of wearable devices

The American Academy of Neurology provides guidance on the use of wearable devices for neurological care, highlighting their benefits and limitations. Wearable devices can serve as screening tools for heart rate and cardiac arrhythmia, and can be helpful in disease management for epilepsy, but their use also carries risks and limitations.

SourceAmerican Academy of Neurology·JournalNeurology·DateMar 11, 2026

Maternal acetaminophen use and child neurodevelopment

A study in Taiwan found a positive association between maternal prenatal acetaminophen use and increased risk of attention-deficit/hyperactivity disorder (ADHD) and autism spectrum disorders (ASDs) in offspring. However, associations were not observed in sibling-matched analyses, suggesting unaddressed sources of bias.

SourceJAMA Network·JournalJAMA Pediatrics·DateMar 9, 2026

Many patients want to talk about their faith. Neurologists often don't know how.

Patients with neurological diseases face profound questions about identity, purpose, and meaning, but neurologists often lack training and tools to address these concerns. A new paper offers practical strategies for incorporating spiritual assessment into routine neurological care.

SourceUniversity of California - Los Angeles Health Sciences·JournalNeurology Clinical Practice·TypeCommentary/editorial·DateMar 9, 2026